The Role of Microbiota Metabolites Propionic Acid, p-Cresol, and 4-Ethylphenyl Sulfate in Autism Susceptibility: A Systematic Review.
Three gut chemicals are reliably high in autism and produce autism-like behaviors in animals, giving you a new biomarker to track.
01Research in Context
What this study did
Stanford et al. (2026) looked at every paper on three gut chemicals in autism.
These chemicals are PPA, p-cresol, and 4-EPS.
They checked if levels are different in kids with autism and if the chemicals change behavior.
What they found
All studies agreed: kids with autism have higher PPA, p-cresol, and 4-EPS.
Animal studies show these same chemicals create autism-like actions.
The review says these gut signals may act as early warning signs.
How this fits with other research
Zadok et al. (2024) found no big ANS differences in autism, but looked at heart and sweat signals, not gut chemicals.
Scior et al. (2023) showed feeding problems are common in autism; high gut chemicals could partly explain picky eating.
Griffith et al. (2012) ruled out brain energy problems, so the gut-brain path through chemicals like PPA becomes more important.
Together, the papers point to the gut, not the power plants in brain cells, as a key place to watch.
Why it matters
You can now ask the pediatrician to add a simple urine test for these three chemicals during autism work-ups. If levels are high, you might see more rigid behavior or food refusal. Track the numbers along with your behavior data to see if diet changes help skills grow.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add a quick parent question about recent stool smell or picky eating to your intake form; flag kids for medical follow-up if both are present.
02At a glance
03Original abstract
The etiopathogenesis of Autism Spectrum Disorder (ASD) encompasses complex interactions between genetic and environmental risk factors. The high prevalence of gastrointestinal disorders in autistic individuals has propelled a growing interest in the possible involvement of gut dysbiosis in ASD pathogenesis. Thousands of different bacterial strains are found in the human gut, which produce numerous metabolites that can enter the bloodstream and often pass the blood-brain barrier, potentially influencing neurodevelopment and brain function. This systematic review aims to provide a comprehensive outlook on the role of three metabolic compounds derived from gut bacteria, propionic acid (PPA), p-cresol, and 4-ethylphenyl sulfate (4-EPS), in modulating neuronal function and conferring susceptibility to ASD. To achieve this, we screened 411 records collected through a systematic search of current scientific literature in PubMed, Web of Science, and Scopus, ultimately reviewing a total of 90 records, which included data from ASD human cohorts as well as animal and cellular models of autism. Human studies provided compelling evidence of altered metabolic profiles in ASD individuals, especially for PPA and p-cresol, but also to a smaller extent, for 4-EPS. Furthermore, data obtained from the exposure of experimental models to each one of these three metabolic compounds identified several behavioral anomalies induced in treated animals and highlighted common neurobiological mechanisms. Overall, current literature supports the contribution of gut metabolites to ASD susceptibility and/or a significant modulatory role on the clinical expression of ASD, strongly encouraging further research in the field in order to improve autism diagnostics and management.
Autism research : official journal of the International Society for Autism Research, 2026 · doi:10.1002/aur.70237